147 results on '"Akkerhuis, K. Martijn"'
Search Results
2. Sex-based differences in cardiovascular proteomic profiles and their associations with adverse outcomes in patients with chronic heart failure
3. Targeted proteomics and metabolomics for biomarker discovery in abdominal aortic aneurysm and post-EVAR sac volume
4. HFrEF subphenotypes based on 4210 repeatedly measured circulating proteins are driven by different biological mechanisms
5. Heart failure subphenotypes based on repeated biomarker measurements are associated with clinical characteristics and adverse events (Bio-SHiFT study)
6. Dynamic personalized risk prediction in chronic heart failure patients: a longitudinal, clinical investigation of 92 biomarkers (Bio-SHiFT study)
7. Proteomic biomarkers related to obesity in heart failure with reduced ejection fraction and their associations with outcome.
8. Temporal evolution of liver function parameters predicts clinical outcome in chronic heart failure patients (Bio-SHiFT study).
9. A heart failure phenotype stratified model for predicting 1-year mortality in patients admitted with acute heart failure: results from an individual participant data meta-analysis of four prospective European cohorts
10. Temporal Pattern of Growth Differentiation Factor-15 Protein After Acute Coronary Syndrome (From the BIOMArCS Study)
11. Prognostic Value of Intravascular Ultrasound in Patients With Coronary Artery Disease
12. Sex‐specific cardiovascular protein levels and their link with clinical outcome in heart failure.
13. Effects of Ticagrelor, Prasugrel, or Clopidogrel on Endothelial Function and Other Vascular Biomarkers: A Randomized Crossover Study
14. Serially measured circulating miR-22-3p is a biomarker for adverse clinical outcome in patients with chronic heart failure: The Bio-SHiFT study
15. Circulating biomarkers of cardiovascular disease are related to aneurysm volume in abdominal aortic aneurysm.
16. Plasma cystatin C and neutrophil gelatinase-associated lipocalin in relation to coronary atherosclerosis on intravascular ultrasound and cardiovascular outcome: Impact of kidney function (ATHEROREMO-IVUS study)
17. Haptoglobin polymorphism in relation to coronary plaque characteristics on radiofrequency intravascular ultrasound and near-infrared spectroscopy in patients with coronary artery disease
18. PCSK9 in relation to coronary plaque inflammation: Results of the ATHEROREMO-IVUS study
19. High-sensitivity Troponin T in relation to coronary plaque characteristics in patients with stable coronary artery disease; results of the ATHEROREMO-IVUS study
20. Plasma concentrations of molecular lipid species in relation to coronary plaque characteristics and cardiovascular outcome: Results of the ATHEROREMO-IVUS study
21. Serially measured high-sensitivity cardiac troponin T, N-terminal-pro-B-type natriuretic peptide, high-sensitivity C-reactive protein, and growth differentiation factor 15 for risk assessment after acute coronary syndrome: the BIOMArCS cohort.
22. Circulating acute phase proteins in relation to extent and composition of coronary atherosclerosis and cardiovascular outcome: Results from the ATHEROREMO-IVUS study
23. Relation of C-Reactive Protein to Coronary Plaque Characteristics on Grayscale, Radiofrequency Intravascular Ultrasound, and Cardiovascular Outcome in Patients With Acute Coronary Syndrome or Stable Angina Pectoris (from the ATHEROREMO-IVUS Study)
24. Development and validation of a risk model for long‐term mortality after percutaneous coronary intervention: The IDEA‐BIO Study
25. Impact of intra-aortic balloon pump support initiated before versus after primary percutaneous coronary intervention in patients with cardiogenic shock from acute myocardial infarction
26. CXCL10 Is a Circulating Inflammatory Marker in Patients with Advanced Heart Failure: a Pilot Study
27. Longitudinal profile of circulating endothelial cells in post-acute coronary syndrome patients.
28. Effect of Anemia on Short- and Long-Term Outcome in Patients Hospitalized for Acute Coronary Syndromes
29. Prognostic value of syntax score, intravascular ultrasound and near-infrared spectroscopy to identify low-risk patients with coronary artery disease 5-year results from the ATHEROREMO and IBIS-3 cohorts.
30. Stent thrombosis in early-generation drug-eluting stents versus newer-generation everolimus-eluting stent assorted by LVEF
31. Prognostic Significance of QRS Duration in Patients With Suspected Coronary Artery Disease Referred for Noninvasive Evaluation of Myocardial Ischemia
32. In vivo detection of high-risk coronary plaques by radiofrequency intravascular ultrasound and cardiovascular outcome: results of the ATHEROREMO-IVUS study
33. Persistently elevated levels of sST2 after acute coronary syndrome are associated with recurrent cardiac events.
34. Biomarkers of heart failure with normal ejection fraction: a systematic review
35. Short- and Long-Term Mortality After Myocardial Infarction in Patients With and Without Diabetes: Changes from 1985 to 2008
36. Determinants of quality of life in acute heart failure patients with and without comorbidities: a prospective, observational study.
37. Angiotensin-converting enzyme inhibitors reduce mortality in hypertension: a meta-analysis of randomized clinical trials of renin–angiotensin–aldosterone system inhibitors involving 158 998 patients
38. IGF-1 is not related to long-term outcome in hyperglycemic acute coronary syndrome patients.
39. Personalized screening intervals for kidney function in patients with chronic heart failure: a modeling study.
40. Personalized screening intervals for measurement of N-terminal pro-B-type natriuretic peptide improve efficiency of prognostication in patients with chronic heart failure.
41. Left ventricular remodelling and prognosis after discharge in new‐onset acute heart failure with reduced ejection fraction.
42. Risk of Stroke Associated With Abciximab Among Patients Undergoing Percutaneous Coronary Intervention
43. Associations of serially measured PCSK9, LDLR and MPO with clinical outcomes in heart failure.
44. Temporal Evolution of Serum Concentrations of High-Sensitivity Cardiac Troponin During 1 Year After Acute Coronary Syndrome Admission.
45. Stabilization patterns and variability of hs-CRP, NT-proBNP and ST2 during 1 year after acute coronary syndrome admission: results of the BIOMArCS study.
46. Temporal patterns of macrophage‐ and neutrophil‐related markers are associated with clinical outcome in heart failure patients.
47. Renal tubular damage and worsening renal function in chronic heart failure: Clinical determinants and relation to prognosis (Bio‐SHiFT study).
48. High-frequency metabolite profiling and the incidence of recurrent cardiac events in patients with post-acute coronary syndrome.
49. Longitudinally Measured Fibrinolysis Factors are Strong Predictors of Clinical Outcome in Patients with Chronic Heart Failure: The Bio-SHiFT Study.
50. Temporal evolution of myeloperoxidase and galectin 3 during 1 year after acute coronary syndrome admission.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.